Short answer
Olema Pharmaceuticals, Inc. (OLMA) filed an 8-K current report with the SEC on June 23, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All four Class III director nominees elected through the 2029 annual meeting.
Olema Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All four Class III director nominees elected through the 2029 annual meeting
- Yi Larson received 50,371,668 votes for and 18,268,079 withheld, signaling comparatively weaker shareholder support
- Executive compensation approved advisory basis with 67,969,902 votes for and 653,979 against
- Ernst & Young LLP ratified as independent auditor for year ending December 31, 2026
- Director elections and compensation vote included 7,496,139 broker non-votes
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Olema Pharmaceuticals, Inc. 8-K filings
Get the next OLMA 8-K as it lands
Follow OLMA for push alerts, or ask the research agent what this filing means.